What is Newamsterdam Pharma Co NV (NAMS)?
Newamsterdam Pharma Co NV is a pharmaceutical company involved in the research, development, and commercialization of therapeutic products. The company focuses on developing treatments for various medical conditions, including those related to oncology, infectious diseases, and rare disorders. Newamsterdam Pharma engages in clinical research and regulatory activities to advance its product candidates through development stages. The company collaborates with healthcare professionals and research institutions to support its drug development programs. Its portfolio may include both proprietary compounds and licensed products aimed at addressing unmet medical needs. Newamsterdam Pharma operates within the pharmaceutical industry framework, adhering to regulatory standards governing drug safety, efficacy, and manufacturing quality. The company aims to contribute to medical science by providing innovative therapies that improve patient outcomes. Its activities encompass preclinical studies, clinical trials, and market authorization processes essential in bringing new medicines to healthcare markets.
Newamsterdam Pharma Co NV Stock Price Today: Live Overview
The price today is shaped by trading activity, with Mama's Creations Inc currently at $31.06. Its intraday price has varied between $29.95 and $31.95, showing a daily percentage change of +3.2377%.
FAQ: Newamsterdam Pharma Co NV (NAMS)
What is the current price of NAMS stock?
Newamsterdam Pharma Co NV's current price is $31.06.
Does NAMS pay dividends?
The company pays dividends via cash distributions (if applicable).
Does NAMS have a formal corporate presence or regional headquarters in the UAE?
Newamsterdam Pharma Co NV has a registered presence in the DIFC, Dubai, UAE.
What is NAMS best known for?
Newamsterdam Pharma Co NV is most famous for its pharmaceutical products focused on respiratory and cardiovascular therapies.
What assets are typically shown together with NAMS?
Commonly shown alongside NAMS: Puretech Health plc, Woolworths Group Limited, Black Diamond Therapeutics, Inc.
Latest shares articles



